Original Research
Published on 04 Jun 2025
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis
in Cancer Molecular Targets and Therapeutics
- 196 views